Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectus Femoris Tenotomy vs Botulinum Toxin A for Stiff Knee Gait
NCT02114736Phase 4Unknown
- Sponsor
- CHU UCL Namur - site Godinne
- Start
- Mar 2014
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial (2 arms), sponsored by CHU UCL Namur - site Godinne. Primary endpoint: Ashworth scale at the rectus femoris at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT02114736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02114736.